Sarepta Therapeutics, Inc. (SRPT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -202.68M | 131.21M | -14.59M | 261.34M | -583.44M | 92.05M | -70.7M | 14.94M | -242.08M | -54.66M | -114.71M | -122.23M | -209.4M | -92.39M | -64.96M | -66.81M | -101.17M | -29.33M | -124.33M | -109.15M |
| Operating CF Margin % | -27.73% | 29.62% | -3.65% | 42.77% | -78.33% | 13.98% | -15.13% | 4.12% | -58.55% | -13.78% | -34.57% | -46.79% | -82.6% | -35.75% | -28.21% | -28.62% | -47.99% | -14.56% | -65.64% | -66.52% |
| Operating CF Growth % | 65.26% | 42.54% | 79.37% | 1649.01% | -141.01% | 268.41% | 38.37% | 112.22% | -15.61% | 40.84% | -76.57% | -82.94% | -106.96% | -215.05% | 47.75% | 38.78% | 43.91% | 83.2% | 47.8% | -1.43% |
| Net Income | 330.96M | -282.85M | -179.95M | 196.89M | -447.51M | 159.05M | 33.61M | 6.46M | 36.12M | 45.66M | -40.94M | -23.94M | -516.75M | -109.24M | -257.74M | -231.48M | -105.03M | -121.98M | -48.14M | -81.41M |
| Depreciation & Amortization | 13.7M | 5.25M | 18.45M | 10.84M | 9.98M | 10.46M | 9.81M | 8.72M | 8.74M | 11.37M | 10.93M | 10.79M | 11.3M | 10.55M | 10.7M | 9.89M | 10.72M | 10.14M | 10.49M | 8.45M |
| Stock-Based Compensation | 0 | 30.02M | 14.93M | 37.02M | 41.43M | 49.68M | 43.45M | 50.48M | 40.69M | 45.83M | 48.06M | 47.38M | 41.25M | 50.51M | 50.42M | 102.89M | 29.2M | 29.78M | 26.68M | 28.97M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.21M | 0 | 0 |
| Other Non-Cash Items | 38.91M | 39.27M | 161.21M | -32.95M | 94.44M | -2.14M | 59.06M | -5.34M | 1.98M | -7.22M | 21.95M | -109.43M | 383.86M | 7.18M | 121.67M | 6.43M | 7.45M | 5.62M | 3.58M | -95.33M |
| Working Capital Changes | -586.25M | 339.51M | -29.23M | 49.53M | -281.78M | -124.99M | -216.62M | -45.38M | -329.61M | -150.29M | -154.71M | -47.03M | -129.06M | -51.39M | 9.99M | 45.45M | -43.52M | 45.9M | -116.95M | 30.17M |
| Change in Receivables | 3.42M | -2.49M | 131.56M | 132.08M | -57.38M | -167.46M | -74.53M | 18.81M | 21.52M | -81.47M | -82.05M | -12.97M | -9.21M | -13.12M | 2.35M | -25.66M | -25.2M | -3.2M | -22.27M | -9.32M |
| Change in Inventory | -69.76M | 18.48M | -83.02M | -59.19M | -177.36M | -161.66M | -70.54M | -102.46M | -60.51M | -94.1M | -26.61M | -26.69M | -306K | -8.88M | -26.54M | -10.68M | -4.69M | -27.26M | -19.71M | -28.42M |
| Change in Payables | -210.47M | 249.62M | 0 | 0 | 0 | 124.21M | 1.69M | 0 | 0 | 61.09M | -17.55M | 0 | -67.54M | 12.88M | 53.2M | 86.52M | -5.02M | 69.81M | -52.96M | 51.41M |
| Cash from Investing | -134.39M | 96.21M | 232.4M | 32.21M | -291.18M | 764.12M | -128.82M | -98.53M | 218.8M | -64.36M | -210.57M | 96.63M | 12.49M | 9.8M | 19.12M | -289.99M | -785.81M | -2.58M | 20.27M | 321.06M |
| Capital Expenditures | -3.08M | -3.59M | -22.93M | -31.8M | -43.65M | -38.08M | -37.26M | -29.17M | -32.44M | -19.04M | -29.67M | -17.91M | -9.48M | -7.96M | -8.23M | -9.08M | -5.55M | -2.21M | -9.24M | -5.89M |
| CapEx % of Revenue | 0.42% | 0.81% | 5.74% | 5.2% | 5.86% | 5.78% | 7.98% | 8.04% | 7.85% | 4.8% | 8.94% | 6.86% | 3.74% | 3.08% | 3.57% | 3.89% | 2.63% | 1.09% | 4.88% | 3.59% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 241.25M | -77.04M | -188K | -2.24M | 0 | 0 | 0 | -10M | 0 | -11.1M | 101.95M | -94K | -1.2M | -507K | -232K | -486K | -371K | -495K | 100.95M |
| Cash from Financing | 241K | -39.21M | -117.79M | -23.82M | 12.47M | 48.99M | 13.76M | 39.92M | 22.14M | 1.94M | 15.4M | 5.86M | 101.8M | 10.75M | 216.43M | 339K | 4.99M | 549.25M | 5.9M | 3.53M |
| Debt Issued (Net) | 0 | -35.13M | -123.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 241K | 198K | 20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 548.53M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -4.27M | -13.85M | -23.82M | 12.47M | 48.99M | 13.76M | 39.92M | 22.14M | 1.94M | 15.4M | 5.86M | 101.8M | 10.75M | 216.43M | 339K | 4.99M | 716K | 5.9M | 3.53M |
| Net Change in Cash | -336.83M | 188.21M | 100.03M | 269.73M | -862.14M | 905.15M | -185.77M | -43.67M | -1.14M | -117.07M | -309.87M | -19.74M | -95.11M | -71.85M | 170.58M | -356.47M | -881.99M | 517.35M | -98.16M | 215.44M |
| Free Cash Flow | -204.76M | 125.38M | -42.83M | 229.35M | -629.33M | 53.96M | -107.96M | -14.22M | -284.52M | -73.7M | -155.48M | -140.19M | -218.97M | -100.36M | -74.42M | -75.89M | -106.73M | -31.53M | -133.57M | -115.04M |
| FCF Margin % | -28.02% | 28.31% | -10.72% | 37.53% | -84.49% | 8.2% | -23.11% | -3.92% | -68.81% | -18.57% | -46.86% | -53.66% | -86.38% | -38.83% | -32.32% | -32.5% | -50.62% | -15.65% | -70.52% | -70.11% |
| FCF Growth % | 67.46% | 132.33% | 60.33% | 1712.32% | -121.19% | 173.23% | 30.56% | 89.85% | -29.93% | 26.57% | -108.92% | -84.72% | -105.17% | -218.27% | 44.28% | 34.03% | 47.04% | 84.48% | 49.31% | 9.25% |
| FCF per Share | -1.68 | 1.20 | -0.43 | 2.15 | -6.46 | 0.50 | -1.07 | -0.14 | -2.87 | -0.70 | -1.75 | -1.58 | -2.48 | -1.14 | -0.85 | -0.87 | -1.22 | -0.37 | -1.67 | -1.44 |
| FCF Conversion (FCF/Net Income) | -0.61x | -0.46x | 0.08x | 1.33x | 1.30x | 0.58x | -2.10x | 2.31x | -6.70x | -1.20x | 2.80x | 5.11x | 0.41x | 0.85x | 0.25x | 0.29x | 0.96x | 0.24x | 2.58x | 1.34x |
| Interest Paid | 0 | 0 | 6.77M | 0 | 7.19M | 687K | 7.19M | 793K | 7.19M | 794K | 7.31M | 794K | 7.02M | 3.15M | 13.49M | 16.09M | 11.69M | 0 | 11.95M | 16.09M |
| Taxes Paid | 0 | 0 | 1.16M | 19.26M | 835K | 10.97M | 3.62M | 7.08M | 909K | 5.51M | 3.58M | 5.46M | 535K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |